Contamination of Mesenchymal Stem-Cells with Fibroblasts Accelerates Neurodegeneration in an Experimental Model of Parkinson's Disease

Stem Cell Reviews and Reports

Volumn 7, Issue 4, 2011, Pages 1006-1017

  Pereira, Marcia C L ^a   Secco, Mariane ^b   Suzuki, Daniela E ^a   Janjoppi, Luciana ^a   Rodini, Carolina O ^a   Torres, Layla B ^a,c   Araújo, Bruno H S ^a   Cavalheiro, Esper A ^a   Zatz, Mayana ^b   Okamoto, Oswaldo Keith ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Cell therapy; Fibroblasts; Mesenchymal stem cells; Parkinson's disease; Umbilical cord

Indexed keywords

EID: 85027928743     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9256-4     Document Type: Article

References (36)

1. Lindvall, O., Brundin, P., Widner, H., et al. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574-577.
2. Freed, C. R., Breeze, R. E., Rosenberg, N. L., et al. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. New England Journal of Medecine, 327, 1549-1555.
3. Freed, C. R., Geene, P. E., Breeze, R. E., et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. New England Journal of Medecine, 344, 710-719.
4. Olanow, C. W., Goetz, C. G., Kordower, J. H., et al. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Annals of Neurology, 54, 403-414.
5. Isacson, O. (2009). Cell therapy ahead for Parkinson's disease. Science, 326, 358-359.
6. Preynat-Seauve, O., Burkhard, P. R., Villard, J., et al. (2009). Pluripotent stem cells as new drugs? The example of Parkinson's disease. Internacional Journal Pharmaceutics, 381, 113-121.
7. Lindvall, O., & Kokaia, Z. (2009). Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends in Pharmacological Sciences, 30, 260-267.
8. Fu, Y., Cheng, Y., Anya, L. M., et al. (2006). Conversion of human umbilical cord mesenquimal stem cells in Wharton's Jelly to dopaminergic neurons in vitro: potencial terapeutic application for Parkinsonism. Stem Cells, 24, 115-124.
9. Weiss, M. L., Medicetty, S., Bledsoe, A. R., et al. (2006). Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells, 24, 781-792.
10. Sadan, O., Shemesh, N., Barzilay, R., et al. (2008). Migration of neurotrophic factors-secreting mesenchymal stem cells towards a quinolinic acid lesion as viewed by MRI. Stem Cells, 26, 2542-2551.
11. Sadan, O., Bahaat-Stromza, M., Barhun, Y., et al. (2009). Protective effects of neurotrophic factors-secreting cells in a 6-OHDA rat model of Parkinson's Disease. Stem Cells and Development, 18, 1-12.
12. Roy, N. S., Cleren, C., Singh, S. K., et al. (2006). Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nature Medicine, 12, 1259-1268.
13. Ravindran, G., & Rao, H. S. (2006). Enriched NCAM-positive cells form functional dopaminergic neurons in the rat model of Parkinson's disease. Stem Cells and Development, 15, 575-582.
14. Bjugstad, K. B., Teng, Y. D., Redmond, D. E. J., et al. (2008). Human neural stem cells migrate along the nigroestriatal pathaway in a primate model of Parkinson's Disease. Experimental Neurology, 211, 362-369.
15. Cho, M. S., Lee, Y. E., Kim, J. Y., et al. (2008). Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences, 105, 3392-3397.
16. Wernig, M., Zhao, J. P., Pruszak, J., et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's Disease. Proceedings of the National Academy of Sciences, 105, 5856-5861.
17. Park, I. H., Arora, N., Huo, H., et al. (2008). Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
18. Wei, P., Liu, J., Zhou, H., et al. (2007). Effects of engrafted neural stem cells derived from GFP transgenic mice in Parkinson's diseases rats. Neuroscience Letters, 419, 49-54.
19. Li, J. Y., Englund, E., Holton, J. L., et al. (2008). Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Medicine, 14, 501-503.
20. Secco, M., Zucconi, E., Vieira, N. M., et al. (2008). Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells, 26, 146-150.
21. Secco, M., Moreira, Y. B., Zucconi, E., et al. (2009). Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem Cell Reviews, 5, 387-401.
22. Morandi, F., Raffaghello, L., Bianchi, G., et al. (2008). Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells, 26, 1275-1287.
23. Prediger, R. D. S., Batista, L. C., Medeiros, R., et al. (2006). The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease. Experimental Neurology, 202, 391-403.
24. Fredriksson, A., & Archer, T. (1994). MPTP-induced behavioural and biochemical deficits: a parametric analysis. Journal of Neural Transmission Parkinson Disease and Dementia Section, 7, 123-132.
25. Cryan, J. F., Mombereau, C., & Vassout, A. (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurocience Biobehavioral Reviews, 29, 571-625.
26. Frussa-Filho, R., Otoboni, J. R., Uema, F. T., et al. (1991). Evaluation of memory and anxiety in rats observed in the eleveted plus-maze: effects of age and isolation. Brazilian Journal of Medicine and Biological Research, 24, 725-728.
27. West, M. J., Slomianka, L., & Gundersen, H. J. (1991). Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. The Anatomical Record, 231, 482-497.
28. Paxinos, G., & Watson, C. (1995). The rat brain: In stereotaxic coordinates (2nd ed.). San Diego: Academic.
29. Korkmaz, A., & Tümkaya, L. (1997). Estimation of the section thickness and optical disector height with a simple calibration method. Journal of Microscopy, 187, 104-109.
30. Glaser, E. M., & Wilson, P. D. (1998). The coefficient of error of optical fractionator population size estimates: a computer simulation comparing three estimators. Journal of Microscopy, 192, 163-171.
31. Hardman, C. D., Henderson, J. M., Finkelstein, D. I., et al. (2002). Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. The Journal of Comparative Neurology, 445, 238-255.
32. Lewis, M. M., Smith, A. B., Styner, M., et al. (2009). Asymmetrical lateral ventricular enlargement in Parkinson's disease. European Journal of Neurology, 16, 475-481.
33. Amor, S., Puentes, F., Baker, D., & van der Valk, P. (2010). Inflammation in neurodegenerative diseases. Immunology, 129, 154-169.
34. Bjorklund, L. M., Sanchez-Pernaute, R., Chung, S., et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proceedings of the National Academy of Sciences, 99, 2344-2349.
35. Crigler, L., Robey, R. C., Asawachaicharm, A., et al. (2006). Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology, 198, 54-64.
36. Lee, P. J., Baek, R. C., Clark, D., et al. (2007). Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nature Medicine, 13, 439-447.